Proteomic strategies to characterize signaling pathways.

[1]  E. Petricoin,et al.  Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines , 2012, International journal of cancer.

[2]  L. Castagnoli,et al.  The 4G10, pY20 and p-TYR-100 antibody specificity: profiling by peptide microarrays. , 2012, New biotechnology.

[3]  F. White,et al.  The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation. , 2012, Cancer research.

[4]  S. Eschrich,et al.  Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. , 2012, Cancer research.

[5]  R. Bose,et al.  Identification of Targets of c-Src Tyrosine Kinase by Chemical Complementation and Phosphoproteomics* , 2012, Molecular & Cellular Proteomics.

[6]  H. Zou,et al.  Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. , 2012, Journal of proteome research.

[7]  Akhilesh Pandey,et al.  TSLP Signaling Network Revealed by SILAC-Based Phosphoproteomics* , 2012, Molecular & Cellular Proteomics.

[8]  Bin Zhang,et al.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..

[9]  L. Huber,et al.  Mapping in vivo signal transduction defects by phosphoproteomics. , 2012, Trends in molecular medicine.

[10]  M. Lackner,et al.  Monitoring phosphoproteomic response to targeted kinase inhibitors using reverse-phase protein microarrays. , 2012, Methods in molecular biology.

[11]  B. Blagoev,et al.  Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. , 2011, Journal of proteomics.

[12]  T. Köcher,et al.  Universal and confident phosphorylation site localization using phosphoRS. , 2011, Journal of proteome research.

[13]  A. Heck,et al.  Investigating the role of FGF‐2 in stem cell maintenance by global phosphoproteomics profiling , 2011, Proteomics.

[14]  Naveid A Ali,et al.  Quantitative phosphoproteomics of transforming growth factor‐β signaling in colon cancer cells , 2011, Proteomics.

[15]  Albert J R Heck,et al.  Enhancing the Identification of Phosphopeptides from Putative Basophilic Kinase Substrates Using Ti (IV) Based IMAC Enrichment* , 2011, Molecular & Cellular Proteomics.

[16]  B. Al-Lazikani,et al.  A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma , 2011, Science Translational Medicine.

[17]  G. Mills,et al.  Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition , 2011, Oncogene.

[18]  B. Snel,et al.  Tyrosine Phosphorylation Profiling in FGF-2 Stimulated Human Embryonic Stem Cells , 2011, PloS one.

[19]  Lixia Diao,et al.  Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR. , 2011, Journal of proteome research.

[20]  J. Chernoff,et al.  Identification of the Atypical MAPK Erk3 as a Novel Substrate for p21-activated Kinase (Pak) Activity* , 2011, The Journal of Biological Chemistry.

[21]  Kumaran Kandasamy,et al.  Identification of Novel Phosphorylation Motifs Through an Integrative Computational and Experimental Analysis of the Human Phosphoproteome. , 2011, Journal of proteomics & bioinformatics.

[22]  E. Petricoin,et al.  Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. , 2011, The American journal of pathology.

[23]  H. Kosako,et al.  Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways , 2011, Expert review of proteomics.

[24]  F. Gillardon,et al.  Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity , 2010, PloS one.

[25]  Theresa Zhang,et al.  Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors , 2010, Science Translational Medicine.

[26]  L. Liotta,et al.  Monitoring Proteins and Protein Networks Using Reverse Phase Protein Arrays , 2010, Disease markers.

[27]  H. Cooper,et al.  Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events , 2010, Journal of proteome research.

[28]  J. Shabanowitz,et al.  Extensive Crosstalk Between O-GlcNAcylation and Phosphorylation Regulates Cytokinesis , 2010, Science Signaling.

[29]  Gary D Bader,et al.  NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.

[30]  R. Cole,et al.  Identification of c‐Src tyrosine kinase substrates in platelet‐derived growth factor receptor signaling , 2009, Molecular oncology.

[31]  K. Nagano,et al.  Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment , 2009, Proteomics.

[32]  K. Resing,et al.  Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. , 2009, Molecular cell.

[33]  Cédric Leroy,et al.  Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. , 2009, Cancer research.

[34]  George M. Church,et al.  Predicting Protein Post-translational Modifications Using Meta-analysis of Proteome Scale Data Sets*S , 2009, Molecular & Cellular Proteomics.

[35]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[36]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[37]  D. Fenyö,et al.  Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer. , 2008, Journal of proteome research.

[38]  P. Bork,et al.  Linear Motif Atlas for Phosphorylation-Dependent Signaling , 2008, Science Signaling.

[39]  Akhilesh Pandey,et al.  Identification of c-Src Tyrosine Kinase Substrates Using Mass Spectrometry and Peptide Microarrays , 2008, Journal of proteome research.

[40]  Daniel MacLean,et al.  PhosCalc: A tool for evaluating the sites of peptide phosphorylation from Mass Spectrometer data , 2008, BMC Research Notes.

[41]  A. Pandey,et al.  Global impact of oncogenic Src on a phosphotyrosine proteome. , 2008, Journal of proteome research.

[42]  Gavin MacBeath,et al.  A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. , 2008, Molecular bioSystems.

[43]  R. Annan,et al.  Hydrophilic Interaction Chromatography Reduces the Complexity of the Phosphoproteome and Improves Global Phosphopeptide Isolation and Detection*S , 2008, Molecular & Cellular Proteomics.

[44]  Xinning Jiang,et al.  Large‐scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography , 2008, Proteomics.

[45]  Akhilesh Pandey,et al.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture , 2008, Nature Protocols.

[46]  M. Mann,et al.  Dissection of the insulin signaling pathway via quantitative phosphoproteomics , 2008, Proceedings of the National Academy of Sciences.

[47]  Allegra Via,et al.  Phospho.ELM: a database of phosphorylation sites—update 2008 , 2007, Nucleic Acids Res..

[48]  R. Hruban,et al.  Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. , 2007, Journal of proteome research.

[49]  A. Alpert.  Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. , 2008, Analytical chemistry.

[50]  H. Zou,et al.  Immobilized Zirconium Ion Affinity Chromatography for Specific Enrichment of Phosphopeptides in Phosphoproteome Analysis*S , 2007, Molecular & Cellular Proteomics.

[51]  Forest M White,et al.  Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma , 2007, Proceedings of the National Academy of Sciences.

[52]  R. Tibshirani,et al.  Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. , 2007, Blood.

[53]  S. Mathivanan,et al.  A curated compendium of phosphorylation motifs , 2007, Nature Biotechnology.

[54]  Suresh Mathivanan,et al.  Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry , 2007, Proceedings of the National Academy of Sciences.

[55]  Steven P. Gygi,et al.  Large-scale phosphorylation analysis of mouse liver , 2007, Proceedings of the National Academy of Sciences.

[56]  G. Hampton,et al.  A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. , 2006, Biochemistry.

[57]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[58]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[59]  Kimberly Lee,et al.  Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. , 2006, Leukemia research.

[60]  E. Petricoin,et al.  Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S , 2006, Molecular & Cellular Proteomics.

[61]  Ron Bose,et al.  Phosphoproteomic analysis of Her2/neu signaling and inhibition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Pandey,et al.  Chemical Rescue of a Mutant Enzyme in Living Cells , 2006, Science.

[63]  Daniel S Spellman,et al.  Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC). , 2006, Journal of proteome research.

[64]  D. Lauffenburger,et al.  Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules*S , 2005, Molecular & Cellular Proteomics.

[65]  P. Roepstorff,et al.  Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.

[66]  Jorng-Tzong Horng,et al.  KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites , 2005, Nucleic Acids Res..

[67]  M. Mann,et al.  Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S , 2005, Molecular & Cellular Proteomics.

[68]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[69]  Paul J Utz,et al.  Protein microarrays for multiplex analysis of signal transduction pathways , 2004, Nature Medicine.

[70]  M. Mann,et al.  Tyrosine Phosphoproteomics of Fibroblast Growth Factor Signaling , 2004, Journal of Biological Chemistry.

[71]  Steven P Gygi,et al.  Large-scale characterization of HeLa cell nuclear phosphoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Mann,et al.  Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics , 2004, Nature Biotechnology.

[73]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[74]  Akira Sano,et al.  Titania as a Chemo-affinity Support for the Column-switching HPLC Analysis of Phosphopeptides: Application to the Characterization of Phosphorylation Sites in Proteins by Combination with Protease Digestion and Electrospray Ionization Mass Spectrometry , 2004, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[75]  Emanuel F Petricoin,et al.  Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays , 2003, Proteomics.

[76]  Michael B. Yaffe,et al.  Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..

[77]  Blagoy Blagoev,et al.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.

[78]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[79]  P. Schultz,et al.  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Matthias Mann,et al.  A Mass Spectrometry-based Proteomic Approach for Identification of Serine/Threonine-phosphorylated Proteins by Enrichment with Phospho-specific Antibodies , 2002, Molecular & Cellular Proteomics.

[81]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[82]  J. Shabanowitz,et al.  Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae , 2002, Nature Biotechnology.

[83]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[84]  T. Fleming,et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.

[85]  H. Lodish,et al.  Identification of a Novel Immunoreceptor Tyrosine-based Activation Motif-containing Molecule, STAM2, by Mass Spectrometry and Its Involvement in Growth Factor and Cytokine Receptor Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[86]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[87]  M. Mann,et al.  Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[89]  N. Blom,et al.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. , 1999, Journal of molecular biology.

[90]  P. Cao,et al.  Phosphopeptide analysis by on-line immobilized metal-ion affinity chromatography-capillary electrophoresis-electrospray ionization mass spectrometry. , 1999, Journal of chromatography. A.

[91]  M. Posewitz,et al.  Immobilized gallium(III) affinity chromatography of phosphopeptides. , 1999, Analytical chemistry.

[92]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[93]  J. Porath,et al.  Model studies on iron(III) ion affinity chromatography. II. Interaction of immobilized iron(III) ions with phosphorylated amino acids, peptides and proteins. , 1992, Journal of chromatography.

[94]  M. Posner,et al.  Generation of monoclonal antibodies against phosphotyrosine and their use for affinity purification of phosphotyrosine-containing proteins. , 1991, Methods in enzymology.

[95]  M. Kamps.  Generation and use of anti-phosphotyrosine antibodies for immunoblotting. , 1991, Methods in enzymology.

[96]  J. Wang.  Antibodies for phosphotyrosine: analytical and preparative tool for tyrosyl-phosphorylated proteins. , 1988, Analytical biochemistry.

[97]  J. Porath,et al.  Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. , 1986, Analytical biochemistry.